Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” ...
UnitedHealth Group is far from the perfect stock, but it is an appealing buy because it can learn from its errors and ...
The new year should be a happier one for this beleaguered healthcare giant.
One year after UnitedHealthcare's CEO was shot and killed, the crisis in U.S. health care is intensifying — even for the ...
Nov 18 (Reuters) - UnitedHealth Group (UNH.N), opens new tab said on Tuesday it had named former U.S. Food and Drug Administration commissioner Scott Gottlieb to its board, effective immediately.
UnitedHealth Group's UNH stock hasn’t received the post-earnings rally that investors may have hoped for, but the medical giant was able to provide subtle signs that its operations are stabilizing.
UnitedHealth beat EPS expectations and raised full-year guidance, signaling early signs of stabilization. Operating income fell 51% as rising medical costs and funding cuts continued to pressure ...
UnitedHealth has returned to better-than-expected growth after starting the year swamped by medical costs and then withdrawing its forecast for 2025. Leaders of the health care giant said Tuesday that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results